Hypothesis / aims of study: Lower urinary tract symptoms (LUTS) are common in women. Although many women have primarily storage symptoms, others have a combination of storage and voiding symptoms without having a defined mechanical obstruction. Anti-muscarinic drugs are commonly used to treat women with LUTS whether they have primarily storage or storage and voiding symptoms. It is doubtful tha...

Nocturia is a prevalent and highly bothersome lower urinary tract symptom (LUTS) affecting men and women of all ages. In waking to void there is disruption to an individual’s sleep that can lead to daytime tiredness and a loss of vitality. This may significantly impact upon physical, mental, and social wellbeing. It is recognised that nocturia has a multifactorial aetiopathogenesis that encompa...

Benign Prostatic Hyperplasia (BPH) is a progressive condition characterised by prostate enlargement accompanied by lower urinary tract symptoms (LUTS). It contributes to, but is not the sole cause of LUTS. It is well known that BPH and the resultant LUTS is very common in elderly men and has a great impact on the patients’ quality of life. It was estimated that in the male population, a histolo...

Primary care physicians commonly see men or women with nocturia (or nocturnal polyuria). Nocturia can have a dramatic impact on a patient's physical and emotional quality of life, including work performance or ability to function, because of the interrupted sleep patterns. It has also been determined that the most important sleep interval is the time from first falling asleep until first awaken...

Benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) are highly prevalent in older men. Medical therapy is the first-line treatment for LUTS due to BPH. Alpha-adrenergic receptor blockers remain one of the mainstays in the treatment of male LUTS and clinical BPH. They exhibit early onset of efficacy with regard to both symptoms and flow rate improvement, and this is...

AIMS The purpose of this study was to evaluate lower urinary tract symptoms (LUTS) in idiopathic normal pressure hydrocephalus (iNPH). METHODS Patients with new-onset iNPH were prospectively evaluated for LUTS via detailed history and physical, and administration of questionnaires from the International Consultation on Incontinence to assess incontinence (ICIq-UI), overactive bladder (ICIq-OA...

Saw palmetto extract (SPE), an extract from the ripe berries of the American dwarf palm, has been widely used as a therapeutic remedy for urinary dysfunction due to benign prostatic hyperplasia (BPH) in Europe. Numerous mechanisms of action have been proposed for SPE, including the inhibition of 5alphareductase. Today, alpha(1)-adrenoceptor antagonists and muscarinic cholinoceptor antagonists a...

Abstract Background The aim of the study is to find correlation between prostate volume and severity lower urinary tract symptoms (LUTS) as measured by international score maximum urine flow rate among patients with benign prostatic hyperplasia (BPH). Methods was a prospective correlational conducted June 2016 November 2017. A total 290 who presented LUTS suggestive BPH satisfied inclusion crit...

Lower urinary tract symptoms (LUTS) in aging men are extremely common. They have historically been attributed to benign prostatic hyperplasia (BPH), enlargement of the prostate, and bladder outlet obstruction. However, recent studies have revealed acute and chronic inflammation to be highly associated with LUTS, correlated with prostatic enlargement, and implicated as a cause of prostatic fibro...

PURPOSE To determine if switching from one brand of the α1-adrenoceptor antagonist naftopidil (Avishot™) to another brand (Flivas™) under the same conditions causes the same changes in lower urinary tract symptoms (LUTS) and quality of life (QOL) as the perceived placebo effect, and if ambient temperature as a nonspecific factor is related to those changes in benign prostatic hyperplasia (BPH) ...